• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHB0501331 低分子肝素钙 heparin calcium Active ingredient Chemical Drugs Supplementary Application 2005-07-13 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2005-12-02 view
CYHB0810558 低分子肝素钙 heparin calcium Active ingredient Chemical Drugs Supplementary Application 2008-11-24 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2011-09-22 view
CXHB0501332 低分子肝素钙注射液 heparin calcium Injection Chemical Drugs Supplementary Application 2005-07-13 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2006-04-04 view
CXHB0501333 低分子肝素钙注射液 heparin calcium Injection Chemical Drugs Supplementary Application 2005-07-13 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Completed-Pending Issued 2006-03-07 view
CXSL2200444 聚乙二醇重组人促红素注射液 Injection Biological Products(1) New Drug Application 2022-09-07 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd view
CXSL1400113 聚乙二醇重组人促红素注射液 Injection Biological Products(1) New Drug Application 2014-12-25 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2017-01-11 view
CXSB2300011 聚乙二醇重组人促红素注射液 Injection Biological Products(1) Supplementary Application 2023-02-03 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd view
CXSB2300012 聚乙二醇重组人促红素注射液 Injection Biological Products(1) Supplementary Application 2023-02-03 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd view
CYHB1501484 那屈肝素钙 nadroparin calcium Active ingredient Chemical Drugs Supplementary Application 2015-11-13 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd In Review 2015-11-11 view
CYHB2000003 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2020-01-10 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2020-08-17 view
CYHB2301439 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2023-06-29 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd view
CYHB2301440 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2023-06-29 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd view
CYHB2040044 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2020-11-14 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd In Review 2020-11-13 view
CYHB1802449 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2018-05-11 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2018-08-17 view
CYHB2040043 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2020-11-14 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd In Review 2020-11-13 view
CYHB1802448 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2018-05-11 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2018-08-17 view
CYHB2000004 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2020-01-10 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2020-08-17 view
CYHB1301214 那曲肝素钙 nadroparin calcium Active ingredient Chemical Drugs Supplementary Application 2013-05-13 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2014-01-03 view
CYSB0800203 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2008-11-03 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2009-05-05 view
CYSB1500231 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2015-11-09 深圳赛保尔生物药业有限公司 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd Certificate Issued 2016-10-28 view